Taylor Frigon Capital Management LLC Decreases Stock Position in STERIS plc (NYSE:STE)

Taylor Frigon Capital Management LLC cut its holdings in STERIS plc (NYSE:STE) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,218 shares of the medical equipment provider’s stock after selling 63 shares during the quarter. Taylor Frigon Capital Management LLC’s holdings in STERIS were worth $1,278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of STE. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of STERIS by 25.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock worth $2,005,000 after purchasing an additional 1,713 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of STERIS by 32.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock worth $1,869,000 after purchasing an additional 1,904 shares during the last quarter. State of Alaska Department of Revenue grew its stake in shares of STERIS by 6.9% in the third quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock worth $2,778,000 after purchasing an additional 735 shares during the last quarter. First Trust Direct Indexing L.P. grew its stake in shares of STERIS by 46.3% in the third quarter. First Trust Direct Indexing L.P. now owns 4,603 shares of the medical equipment provider’s stock worth $1,116,000 after purchasing an additional 1,456 shares during the last quarter. Finally, Diversify Wealth Management LLC grew its stake in shares of STERIS by 7.8% in the third quarter. Diversify Wealth Management LLC now owns 4,222 shares of the medical equipment provider’s stock worth $934,000 after purchasing an additional 304 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

STERIS Stock Performance

STERIS stock opened at $222.97 on Thursday. The stock’s 50 day simple moving average is $214.13 and its two-hundred day simple moving average is $223.13. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 47.34 and a beta of 0.84. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS’s dividend payout ratio is currently 48.41%.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Stephens reissued an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, Piper Sandler lifted their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.